\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationOnline
ProgrammesResearch Centre Digitalia, together with other Memory Campus organisations, organise a three-day hybrid event called “Digital Archiving Futures”. Themes of the event are “Data Spaces, Artificial Intelligence, and Cluster Collaboration”, featuring speakers from the GLAM sector and information management field from Finland and across Europe. Onsite registration has been closed already, but you can still register to attend online.
The event is free of charge for participants and is organised by Research Centre Digitalia and Memory Campus Cluster, as a part of their project “Memory Campus as an International Cluster for Information Management”, funded by the Finnish South Savo Regional Council from funds allocated to supporting the sustainable growth and vitality of regions.
Read more and register online for the event until the end of August via the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
